Trial intelligence / Profile preview

Continuous Topiramate Treatment in Migraine

NCT01799590Phase 2Completed

Sponsor
Janssen Pharmaceutical
Start
Aug 2007
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of topiramate in migraine, sponsored by Janssen Pharmaceutical. Started Aug 2007; status: completed.

02

Drugs

topiramate
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01799590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01799590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call